IDEX Biometrics ASA , a leading provider of advanced fingerprint identification and authentication solutions, today announced that the Company will list American Depositary Shares (“ADSs”) each representing 75 ordinary shares of the Company (“Ordinary Shares”) on the Nasdaq Capital Market (“Nasdaq”). Nasdaq has approved the ADSs for listing, and they are expected to begin trading under the symbol “IDBA” on 1 March 2021, subject to approval by the U.S. Securities and Exchange Commission (“SEC”).
A registration statement was filed with the SEC to facilitate the creation of a trading market in the United States for ADSs. The Company has not registered any new issuance of securities and is not making any public offering of new shares or private placement of shares in connection with the listing on Nasdaq. The Company’s Ordinary Shares will continue to be admitted to trading on the Oslo Børs.
IDEX has prepared a series of frequently asked questions (“FAQs”) shown below applicable to holders of the Ordinary Shares and to explain the optional process of exchanging Ordinary Shares for ADSs if a shareholder so chooses. For any further questions about the Ordinary Share to ADS exchange process, please contact the Company’s ADS Depositary Bank, The Bank of New York Mellon at DRBrokerSolutions@bnymellon.com.
For further information contact:
Marianne Bøe, Investor Relations
Tel: + 47 918 00186
Derek D’Antilio, Chief financial Officer
Tel: +1 978 273 1344
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow on Twitter @IDEXBiometrics